Skip to content
SIIS — Servicio de Información e Investigación Social. Fundación Eguía-Careaga Fundazioa
Está en:
  • Inicio>
  • Centro de documentación>
  • Catálogo bibliográfico
Hemen zaude:
  • Hasiera>
  • Dokumentazio zentroa>
  • Katalogo bibliografikoa
You are here:
  • Home>
  • Documentation centre>
  • Library catalogue
VuFind
  • Login
    • Bootstrap
    • Siis
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
    • Māori
Advanced
  • BARRIERS AND FACILITATORS TO U...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

BARRIERS AND FACILITATORS TO UNDERGOING HEPATITIS C VIRUS (HCV) TESTING THROUGH DRUG TREATMENT PROGRAMS

Saved in:
STRAUSS, S.M., ET AL., BARRIERS AND FACILITATORS TO UNDERGOING HEPATITIS C VIRUS (HCV) TESTING THROUGH DRUG TREATMENT PROGRAMS. JOURNAL OF DRUG ISSUES, Vol. 38, no. 4 (2008), p. 1161-1186.
Ref. 159368
Location: SIIS R.993 Archivo
Solicitar documento
Palabras clave:
Detección, Drogas ilegales, Drogodependencias, Hepatitis, Programas de desintoxicación, Tests, Utilización de servicios
  • Holdings
  • Description
  • Comments
  • Similar Items
  • Staff View

Internet

Path
Enlace web pago

Similar Items

  • Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs
    by: Schackman, B.R
  • HCV (HEPATITIS C VIRUS) PRE TEST AND POST TEST COUNSELING SERVICES AT DRUG TREATMEN PROGRAMS: MISSED OPPORTUNITIES FOR PRIMARY PREVENTION
    by: MUNOZ-PLAZA, C.E
  • Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users
    by: Roux, P.
  • Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial
    by: Lim, A.
  • ACCEPTABILITY OF HEPATITIS C VIRUS TESTING METHODS AMONG INJECTING DRUG USERS
    by: WHITE, B.

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs